Oaktree Acquisition Corp. III Life Sciences (OACCW) Total Current Liabilities (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences' Total Current Liabilities history runs 3 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• Quarterly Total Current Liabilities rose 53.44% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 53.44% YoY) and the FY2025 annual result came in at $1.3 million, up 78.69% from the prior year.
• Total Current Liabilities was $1.6 million for Q1 2026 at Oaktree Acquisition Corp. III Life Sciences, up from $1.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $1.6 million in Q1 2026 and bottomed at $727323.0 in Q4 2024.
• A 3-year average of $1.2 million and a median of $1.2 million in 2025 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2025 — Total Current Liabilities soared 78.69% — and 2026, when it surged 53.44%.
• Oaktree Acquisition Corp. III Life Sciences' Total Current Liabilities stood at $727323.0 in 2024, then jumped by 78.69% to $1.3 million in 2025, then grew by 24.97% to $1.6 million in 2026.
• Business Quant data shows OACCW's Total Current Liabilities at $1.6 million in Q1 2026, $1.3 million in Q4 2025, and $1.2 million in Q3 2025.